$234 Million is the total value of Kalos Management, Inc.'s 252 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HTGM | Exit | Htg Molecular Diagnostics Inc | $0 | – | -72,858 | -100.0% | -0.01% | – |
CTSO | Exit | CYTOSORBENTS CORP COM NEW | $0 | – | -12,150 | -100.0% | -0.04% | – |
Exit | FS GLOBAL CR OPPORTUNITIES FD | $0 | – | -19,991 | -100.0% | -0.06% | – | |
IPKW | Exit | INVESCO INTERNATIONAL BUYBACK ACHIEVERSA ETFetf | $0 | – | -6,738 | -100.0% | -0.09% | – |
MTUM | Exit | iShares MSCI USA Momentum Factor ETFetf | $0 | – | -1,437 | -100.0% | -0.10% | – |
ABT | Exit | Abbott Laboratories | $0 | – | -2,351 | -100.0% | -0.12% | – |
NVS | Exit | Novartis AG Spons ADR | $0 | – | -3,540 | -100.0% | -0.13% | – |
UPS | Exit | United Parcel Service Inc | $0 | – | -1,833 | -100.0% | -0.14% | – |
SYY | Exit | Sysco Corporation | $0 | – | -5,926 | -100.0% | -0.19% | – |
DGRW | Exit | WISDOMTREE US QLT DIV GRW ETFetf | $0 | – | -9,235 | -100.0% | -0.21% | – |
CORP | Exit | PIMCO INVEST GRADE CORP BND IDX ETFetf | $0 | – | -4,417 | -100.0% | -0.23% | – |
HCAC | Exit | HENNESSY CAP ACQUSTION CORP IV CL A COM | $0 | – | -56,610 | -100.0% | -0.28% | – |
VB | Exit | Vanguard Small-Capetf | $0 | – | -3,819 | -100.0% | -0.29% | – |
XLV | Exit | SPDR Health Care Select Sectoretf | $0 | – | -7,296 | -100.0% | -0.36% | – |
XNTK | Exit | SPDR NYSE Technologyetf | $0 | – | -6,927 | -100.0% | -0.37% | – |
ITOT | Exit | iShares Core S&P Total US Stock Marketetf | $0 | – | -10,532 | -100.0% | -0.38% | – |
REGN | Exit | Regeneron Pharmaceuticals | $0 | – | -2,277 | -100.0% | -0.57% | – |
PFG | Exit | Principal Financial Group Inc | $0 | – | -40,540 | -100.0% | -0.85% | – |
VER | Exit | Vereit Inc Com | $0 | – | -454,006 | -100.0% | -1.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 30 | Q2 2023 | 2.9% |
APPLE INC COM | 29 | Q2 2023 | 2.7% |
ISHARES TRUST | 29 | Q2 2023 | 1.3% |
ISHARES TR | 28 | Q2 2023 | 5.9% |
VANGUARD S&P 500 ETF IV | 28 | Q2 2023 | 4.2% |
ISHARES US HEALTHCARE ETF IV | 28 | Q2 2023 | 4.7% |
VANGUARD TAX-MANAGED FDS | 28 | Q1 2023 | 1.3% |
SPDR S&P EMERGING MRKT SML CP ETF | 28 | Q2 2023 | 1.2% |
ISHARES US TECHNOLOGY ETF | 28 | Q2 2023 | 1.8% |
SPDR S&P 500 VALUE ETF IV | 28 | Q2 2023 | 0.7% |
View Kalos Management, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-10-16 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-05 |
13F-HR | 2023-02-27 |
13F-HR | 2022-11-21 |
13F-HR | 2022-08-12 |
13F-HR | 2022-06-21 |
13F-HR | 2022-02-03 |
13F-HR | 2021-11-10 |
13F-HR | 2021-08-11 |
View Kalos Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.